Attention disorders in adults with epilepsy. Determinants and therapeutic strategies.


Journal

Revue neurologique
ISSN: 0035-3787
Titre abrégé: Rev Neurol (Paris)
Pays: France
ID NLM: 2984779R

Informations de publication

Date de publication:
Mar 2019
Historique:
received: 03 09 2018
revised: 07 12 2018
accepted: 04 01 2019
pubmed: 4 3 2019
medline: 8 8 2019
entrez: 4 3 2019
Statut: ppublish

Résumé

Cognitive consequences in epilepsy are often described in the following domains: verbal memory, language, executive functions, and attention. Attention is involved in all cognitive activities, and attention disorders (AD) are reported in patients with various neurological diseases. This paper proposes to define the concept of AD and its assessment, to consider their determinants in epilepsy and potential therapies (drug or not). ADs are reported in new onset epilepsy, generalized epilepsy of presumed genetic origin, and in focal epilepsy. In focal epilepsy, alertness and divided attention impairment are observed and seem to improve after successful curative surgery. Additional studies are needed to assess the prevalence and nature of AD related to status epilepticus. In the field of therapeutic strategies, anti-epileptic drugs show an impact on AD. Effects of antidepressive drug therapy are not reported, as well as psychotherapy. Cognitive rehabilitation on AD is a promising therapeutic intervention but specific studies are needed to assess its efficacy.

Identifiants

pubmed: 30826090
pii: S0035-3787(18)30813-0
doi: 10.1016/j.neurol.2019.01.394
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

135-140

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

H Brissart (H)

Epileptology unit, neurology department, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France; UMR 7039, CNRS, université de Lorraine, 54500 Nancy, France; Reference, Center for rare Epilepsies, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France. Electronic address: h.brissart@chru-nancy.fr.

N Forthoffer (N)

Epileptology unit, neurology department, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France; Reference, Center for rare Epilepsies, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France.

L Maillard (L)

Epileptology unit, neurology department, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France; UMR 7039, CNRS, université de Lorraine, 54500 Nancy, France; Reference, Center for rare Epilepsies, Nancy hospital, 29, avenue du Maréchal-de-Lattre-de-Tassigny, 54035 Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH